OAC
ANRO icon

OMERS Administration Corp’s Alto Neuroscience ANRO Stock Holding History

OMERS Administration Corp’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-9,700
Closed -$218K – 1156
2026
Q1 		$218K Sell
9,700
-2,700
-22% -$50K ﹤0.01% 897
2025
Q4 		$221K Buy
+12,400
New +$156K ﹤0.01% 892

Other funds holding ANRO

AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SSC
Spruce Street Capital New York $510M AUM
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

OMERS Administration Corp's ANRO Position: Q2 2026 in Review

OMERS Administration Corp sold out of Alto Neuroscience (ANRO) in Q2 2026, closing a stake of 9,700 shares — an estimated $218K sold.

OMERS Administration Corp first reported a position in ANRO in Q4 2025 and held it in 2 quarters. The position peaked at $221K in Q4 2025. 114 funds tracked by Wall St. Rank hold ANRO as of Q2 2026.

  • OMERS Administration Corp reported no remaining Alto Neuroscience position as of Q2 2026 after selling out during the quarter.
  • OMERS Administration Corp sold 9,700 Alto Neuroscience shares in Q2 2026, an estimated $218K.
  • OMERS Administration Corp first reported a position in Alto Neuroscience in Q4 2025 and held it in 2 quarters.
  • OMERS Administration Corp's Alto Neuroscience position peaked at $221K in Q4 2025.
  • 114 funds tracked by Wall St. Rank held Alto Neuroscience as of Q2 2026.

Based on OMERS Administration Corp's 13F filing for Q2 2026, filed 13 Aug 2026.